CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
A Randomized Phase II Study of Leucovorin/5-Fluorouracil with or without Oxaliplatin (LV5FU2 vs. FOLFOX) for Curatively-Resected, Node-Positive Esophageal Squamous Cell Carcinoma
Sung Hee Lim, Young Mog Shim, Se Hoon Park, Hong Kwan Kim, Young Soo Choi, Myung-Ju Ahn, Keunchil Park, Jae Ill Zo, Jong-Mu Sun
Cancer Research and Treatment. 2017;49(3):816-823.   Published online 2016 November 9    DOI: https://doi.org/10.4143/crt.2016.417

Excel Download

A randomized phase II study of leucovorin, 5-fluorouracil with or without oxaliplatin (LV5FU2 vs. FOLFOX) for curatively-resected, node-positive esophageal squamous cell carcinoma
Annals of Oncology. 2016;27:vi218   Crossref logo
Link1 Link2 Link3

A Randomized Phase II Study of Leucovorin/5-Fluorouracil with or without Oxaliplatin (LV5FU2 vs. FOLFOX) for Curatively-Resected, Node-Positive Esophageal Squamous Cell Carcinoma
Cancer Research and Treatment. 2017;49(3):816-823   Crossref logo
Link1 Link2 Link3

Interim Safety Results From a Randomized Trial of Adjuvant Chemotherapy with Lv5Fu2 Vs. Folfox for Esophageal Squamous Cell Carcinoma
Annals of Oncology. 2013;24:iv53   Crossref logo
Link1 Link2 Link3

Oxaliplatin Plus High-Dose Leucovorin and 5-Fluorouracil (FOLFOX 4) in Platinum-Resistant and Taxane-Pretreated Ovarian Cancer: A Phase II Study
Yearbook of Oncology. 2006;2006:128   Crossref logo
Link1 Link2

Combination of Oxaliplatin and 5-Fluorouracil/Leucovorin for Advanced Esophageal Squamous Cell Carcinoma Refractory or Intolerant to Standard Therapies
Case Reports in Oncology. 2019;12(1):304-310   Crossref logo
Link1 Link2

All-trans-retinoic acid (ATRA) plus oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX) versus FOLFOX alone as palliative chemotherapy in patients with advanced hepatocellular carcinoma and extrahepatic metastasis: study protocol for a randomized controlled trial
Trials. 2019;20(1):   Crossref logo
Link1 Link2 Link3

Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-fluorouracil and infusional 5-fluorouracil alone in advanced pancreatic carcinoma patients
Annals of Oncology. 2004;15(10):1576-1577   Crossref logo
Link1 Link2 Link3

A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus
Cancer Chemotherapy and Pharmacology. 2013;71(4):905-911   Crossref logo
Link1 Link2 Link3

A Phase II Study with 5-Fluorouracil, Folinic Acid and Oxaliplatin (FOLFOX-4 Regimen) in Patients with Metastatic Renal Cell Carcinoma
Oncology. 2002;64(1):25-27   Crossref logo
Link1 Link2

6567 Preoperative radiochemotherapy with cisplatin plus infusional high-dose 5-fluorouracil/leucovorin (LV5FU2) in locally-advanced esophageal carcinoma of UICC stages II and III – ongoing study
European Journal of Cancer Supplements. 2009;7(2):380-381   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.